Form 4: KORU Medical Systems: Director Joseph Manko Jr. Reports Share Grant and Ownership Details

Joseph M. Manko Jr., a director and 10% owner of KORU Medical Systems, reported the acquisition of 5,870 shares and disposal of 517,200 shares of common stock on March 31, 2025.

Summary

• On March 31, 2025, Horton Capital Partners Fund, LP (HCPF) received 5,870 shares of Koru Medical Systems, Inc. common stock as compensation for Joseph M. Manko Jr.'s service as a director for the quarter ending March 31, 2025.
• The Form 4 is jointly filed by Horton Capital Management, LLC (HCM), Horton Capital Partners, LLC (HCP), HCPF, and Joseph M. Manko, Jr.
• HCM holds investment and voting power over Koru Medical Systems shares held by HCPF through investment advisory agreements.
• HCP may be deemed the beneficial owner of these shares because it can assume HCM's investment and voting authority if the advisory agreement is terminated.
• HCP is the general partner of HCPF, and Mr. Manko is the managing member of both HCM and HCP.
• Each reporting person disclaims beneficial ownership of the securities except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The stock grant is mildly positive, while the disposal of shares is mildly negative, balancing each other out.

Positives

• The grant of shares to a director can be seen as a positive alignment of interests between the director and the company's shareholders.

Negatives

• The disposal of 517,200 shares could be interpreted negatively by the market, depending on the reason for the sale.

Risks

• The disclaimer of beneficial ownership by the reporting persons, except for their pecuniary interest, could create uncertainty regarding control and influence over the company.

Management Comments

• Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

Industry Context

Form 4 filings are a standard part of regulatory compliance for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for company insiders in the US, similar to insider transaction reporting requirements in other developed markets.
• The level of detail provided in the filing is consistent with SEC guidelines and industry best practices for transparency.

Stakeholder Impact

• The stock transactions by a director may influence investor sentiment and potentially affect the stock price.

Key Dates

Keywords

KORU Medical Systems, Form 4, beneficial ownership, Joseph Manko Jr., Horton Capital, director compensation, stock grant, share disposal